Invest in Yourself—Your WayGive $50, Get $50 Referral ProgramKlarna, Affirm & CareCredit acceptedNew Client Tox Pricing
Weight Loss6 min read

Semaglutide vs. Tirzepatide: Which GLP-1 Is Right for You?

May 26, 2026 · By Paige Erickson, DNP, FNP-C

GLP-1 medications have changed the conversation around medical weight loss. If you've started researching your options, you've probably run into two names again and again: semaglutide and tirzepatide. They're related, they're often discussed together, and they both support meaningful weight loss — but they aren't identical. Here's how they compare, and how our providers at Ren Aesthetics & Wellness in Ogden, UT help you decide.

First, what is a GLP-1?

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces that helps regulate appetite and blood sugar. GLP-1 medications mimic that hormone — slowing digestion, increasing feelings of fullness, and quieting the constant "food noise" that can make weight loss feel like a willpower problem rather than a biological one. The result, for many people, is a more natural, sustainable reduction in how much they eat.

Semaglutide

Semaglutide is a GLP-1 receptor agonist. It acts on a single pathway — the GLP-1 receptor — to curb appetite and support blood-sugar regulation. It has a well-established track record for weight management and is a strong, reliable option for many people beginning their journey.

Tirzepatide

Tirzepatide is a dual-action medication: it targets the GLP-1 receptor and a second one called GIP (glucose-dependent insulinotropic polypeptide). By working on two pathways instead of one, it can offer additional appetite and metabolic support. For some patients, that dual action translates to different results or tolerability compared with semaglutide.

The key differences at a glance

  • Mechanism: semaglutide acts on one receptor (GLP-1); tirzepatide acts on two (GLP-1 and GIP).
  • Approach: both reduce appetite and support blood-sugar balance; tirzepatide's dual action adds another metabolic lever.
  • Fit: the right choice depends on your health history, goals, tolerance, and how your body responds — not on which is 'stronger' on paper.

How do you choose?

This is exactly where medical supervision matters. The better question isn't "which medication is best?" but "which is best for me?" At Ren, that starts with a provider consultation: we review your medical history, goals, and labs, then recommend a starting medication and dose. We begin low, titrate gradually, and monitor your progress — adjusting as your body responds so you get results safely.

What about side effects?

The most common side effects for both medications are mild and digestive — things like nausea or a feeling of fullness — and they typically ease as your body adjusts. Starting at a low dose and increasing slowly is one of the most effective ways to minimize them, which is a core part of how we manage your plan.

Medically supervised GLP-1 care in Ogden

Both semaglutide and tirzepatide can be powerful tools, but they work best as part of a supervised, personalized program. Book a consultation at Ren and our providers will help you understand your options and choose the path that fits your body and your goals.

Related services

Paige Erickson

Written by

Paige Erickson, DNP, FNP-C

Co-Founder & Medical Director

Dr. Paige Erickson is a board-certified Family Nurse Practitioner with 18 years of experience in healthcare. She earned her Doctorate of Nursing Practice from Weber State University and specializes in weight loss, hormone optimization, and peptide therapy, serving as the medical director of the practice.

Frequently asked questions

  • Semaglutide acts on a single pathway (the GLP-1 receptor), while tirzepatide is dual-action, targeting both GLP-1 and GIP receptors for additional appetite and metabolic support.

Have questions? Let's talk.

Book a consultation and our team will help you find the right treatment for your goals.